Article Details

Indaptus Therapeutics, Inc. (NASDAQ:INDP) CEO Jeffrey A. Meckler Purchases 19727 Shares

Retrieved on: 2022-06-07 19:33:54

Tags for this article:

Click the tags to see associated articles and topics

Indaptus Therapeutics, Inc. (NASDAQ:INDP) CEO Jeffrey A. Meckler Purchases 19727 Shares. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 242,235 shares of the company's stock worth $969,000 after acquiring an additional 38,216 shares in the last quarter.

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up